These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 25278909)

  • 21. Coupling Neurogenetics (GARS™) and a Nutrigenomic Based Dopaminergic Agonist to Treat Reward Deficiency Syndrome (RDS): Targeting Polymorphic Reward Genes for Carbohydrate Addiction Algorithms.
    Blum K; Simpatico T; Badgaiyan RD; Demetrovics Z; Fratantonio J; Agan G; Febo M; Gold MS
    J Reward Defic Syndr; 2015; 1(2):75-80. PubMed ID: 27617300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nigrostriatal and Mesolimbic D
    Stark AJ; Smith CT; Lin YC; Petersen KJ; Trujillo P; van Wouwe NC; Kang H; Donahue MJ; Kessler RM; Zald DH; Claassen DO
    J Neurosci; 2018 Mar; 38(13):3230-3239. PubMed ID: 29483278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pro-Dopamine Regulator (KB220) A Fifty Year Sojourn to Combat Reward Deficiency Syndrome (RDS): Evidence Based Bibliography (Annotated).
    Kenneth B; Edward MJ; Marjorie GLC; David B; Bruce S; Panayotis TK; William DB; Davis S; Lisa L; Eric BR; Mark M; David M; Lyle F; Rajendra BD
    CPQ Neurol Psychol; 2018; 1(2):. PubMed ID: 30957097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinically Combating Reward Deficiency Syndrome (RDS) with Dopamine Agonist Therapy as a Paradigm Shift: Dopamine for Dinner?
    Blum K; Febo M; Thanos PK; Baron D; Fratantonio J; Gold M
    Mol Neurobiol; 2015 Dec; 52(3):1862-1869. PubMed ID: 25750061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overcoming qEEG abnormalities and reward gene deficits during protracted abstinence in male psychostimulant and polydrug abusers utilizing putative dopamine D₂ agonist therapy: part 2.
    Blum K; Chen TJ; Morse S; Giordano J; Chen AL; Thompson J; Allen C; Smolen A; Lubar J; Stice E; Downs BW; Waite RL; Madigan MA; Kerner M; Fornari F; Braverman ER
    Postgrad Med; 2010 Nov; 122(6):214-26. PubMed ID: 21084796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuronutrient Amino-Acid Therapy Protects Against Reward Deficiency Syndrome: Dopaminergic Key to Homeostasis and Neuroplasticity.
    Blum K; Febo M; Badgaiyan RD; Braverman ER; Dushaj K; Li M; Demetrovics Z
    Curr Pharm Des; 2016; 22(38):5837-5854. PubMed ID: 27510492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular role of dopamine in anhedonia linked to reward deficiency syndrome (RDS) and anti- reward systems.
    Gold MS; Blum K; Febo M; Baron D; Modestino EJ; Elman I; Badgaiyan RD
    Front Biosci (Schol Ed); 2018 Mar; 10(2):309-325. PubMed ID: 29293435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurological correlates of brain reward circuitry linked to opioid use disorder (OUD): Do homo sapiens acquire or have a reward deficiency syndrome?
    Gold MS; Baron D; Bowirrat A; Blum K
    J Neurol Sci; 2020 Nov; 418():117137. PubMed ID: 32957037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hatching the behavioral addiction egg: Reward Deficiency Solution System (RDSS)™ as a function of dopaminergic neurogenetics and brain functional connectivity linking all addictions under a common rubric.
    Blum K; Febo M; McLaughlin T; Cronjé FJ; Han D; Gold SM
    J Behav Addict; 2014 Sep; 3(3):149-56. PubMed ID: 25317338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reward deficiency syndrome in obesity: a preliminary cross-sectional trial with a Genotrim variant.
    Blum K; Chen TJ; Meshkin B; Downs BW; Gordon CA; Blum S; Mengucci JF; Braverman ER; Arcuri V; Varshavskiy M; Deutsch R; Martinez-Pons M
    Adv Ther; 2006; 23(6):1040-51. PubMed ID: 17276971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurogenetic Impairments of Brain Reward Circuitry Links to Reward Deficiency Syndrome (RDS): Potential Nutrigenomic Induced Dopaminergic Activation.
    Blum K; Oscar-Berman M; Giordano J; Downs B; Simpatico T; Han D; Femino J
    J Genet Syndr Gene Ther; 2012 Oct; 3(4):. PubMed ID: 23264886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between dopaminergic neurotransmission, alcoholism, and Reward Deficiency syndrome.
    Bowirrat A; Oscar-Berman M
    Am J Med Genet B Neuropsychiatr Genet; 2005 Jan; 132B(1):29-37. PubMed ID: 15457501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of dopamine in motivation for food in humans: implications for obesity.
    Wang GJ; Volkow ND; Fowler JS
    Expert Opin Ther Targets; 2002 Oct; 6(5):601-9. PubMed ID: 12387683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A meta-analysis of the relationship between brain dopamine receptors and obesity: a matter of changes in behavior rather than food addiction?
    Benton D; Young HA
    Int J Obes (Lond); 2016 Mar; 40 Suppl 1(Suppl 1):S12-21. PubMed ID: 27001642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemogenetic Manipulations of Ventral Tegmental Area Dopamine Neurons Reveal Multifaceted Roles in Cocaine Abuse.
    Mahler SV; Brodnik ZD; Cox BM; Buchta WC; Bentzley BS; Quintanilla J; Cope ZA; Lin EC; Riedy MD; Scofield MD; Messinger J; Ruiz CM; Riegel AC; España RA; Aston-Jones G
    J Neurosci; 2019 Jan; 39(3):503-518. PubMed ID: 30446532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pro-Dopamine Regulator - (KB220) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome (RDS).
    Blum K; Febo M; Fried L; Baron D; Braverman ER; Dushaj K; Li M; Demetrovics Z; Badgaiyan RD
    J Reward Defic Syndr Addict Sci; 2017; 3(1):3-13. PubMed ID: 28804788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypothesizing That Neuropharmacological and Neuroimaging Studies of Glutaminergic-Dopaminergic Optimization Complex (KB220Z) Are Associated With "Dopamine Homeostasis" in Reward Deficiency Syndrome (RDS).
    Blum K; Febo M; Fried L; Li M; Dushaj K; Braverman ER; McLaughlin T; Steinberg B; Badgaiyan RD
    Subst Use Misuse; 2017 Mar; 52(4):535-547. PubMed ID: 28033474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Putative COVID- 19 Induction of Reward Deficiency Syndrome (RDS) and Associated Behavioral Addictions with Potential Concomitant Dopamine Depletion: Is COVID-19 Social Distancing a Double Edged Sword?
    Blum K; Cadet JL; Baron D; Badgaiyan RD; Brewer R; Modestino EJ; Gold MS
    Subst Use Misuse; 2020; 55(14):2438-2442. PubMed ID: 32957797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS): Clinical Ramifications as a Function of Molecular Neurobiological Mechanisms.
    Blum K; Oscar-Berman M; Stuller E; Miller D; Giordano J; Morse S; McCormick L; Downs WB; Waite RL; Barh D; Neal D; Braverman ER; Lohmann R; Borsten J; Hauser M; Han D; Liu Y; Helman M; Simpatico T
    J Addict Res Ther; 2012 Nov; 3(5):139. PubMed ID: 23926462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "Liking" and "wanting" linked to Reward Deficiency Syndrome (RDS): hypothesizing differential responsivity in brain reward circuitry.
    Blum K; Gardner E; Oscar-Berman M; Gold M
    Curr Pharm Des; 2012; 18(1):113-8. PubMed ID: 22236117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.